When delivered to a tumor cell, miR-3960 downregulates BRSK2 expression, which lowers S16 phosphorylation of PIMREG, enhancing its stability and initiating the NF-κB signaling pathway [96]. This evidence concerns the gene NFKB1 and neoplasm.